Noronex (NRX.AX) Stock Price
Noronex Price
Over the last 8 years Noronex grew revenue by 100.5% annually, reaching 2.31 M AUD. For Noronex, the net margin of 49.6% is up versus -66,185.4% a few years ago.
Noronex stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Noronex business model & stock analysis
Frequently asked questions about Noronex
Converted at the current exchange rate, the Noronex share trades at 0.01 EUR (0.01 AUD).
The revenue of Noronex is 2.31 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Noronex is 1.15 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Noronex is currently 6.13. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Noronex stock.
The price-to-sales ratio (P/S) of Noronex is currently 3.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Noronex stock.
The Eulerpool Quality Score for Noronex is 6/10.
The ISIN of Noronex is AU0000116469. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Noronex is NRX.AX. The ticker symbol is used to trade Noronex shares on the stock exchange.
Noronex stock
Noronex Peer Group
Noronex FIGI
All fundamentals and in-depth analysis of Noronex
Our stock analysis for Noronex stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Noronex. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.